SCHEMBL6509086

SCHEMBL6509086

CON(C)C(=O)CC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.38
SRR Q9GZT4 1/20 0.38
PHF8 Q9UPP1 4/20 0.34
KDM2A Q9Y2K7 4/20 0.34
TSHR P16473 2/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
EGLN1 Q9GZT9 2/20 0.33
KDM7A Q6ZMT4 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM6B O15054 1/20 0.33
KDM5C P41229 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
KDM4A O75164 5/20 0.31
KDM4C Q9H3R0 5/20 0.31
PRMT3 O60678 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30462442 0.87 MEN1 (0.37) TSHRMEN1KMT2ATDP1PKM
SCHEMBL26023825 0.80 MGAM (0.46) PHF8KDM2ATSHRMEN1KMT2A
SCHEMBL15684245 0.78 PHF8 (0.54) PHF8KDM2ATSHREGLN1KDM7A
SCHEMBL7142988 0.78 ALOX15 (0.33) TSHRMEN1KMT2ATDP1PKM
SCHEMBL18505703 0.76 ALDH1A1 (0.34) MEN1KMT2ATDP1PKMRAB9A
SCHEMBL4019745 0.76 PHF8 (0.39) PHF8KDM2ATSHRMEN1KMT2A
SCHEMBL924444 0.75 PRMT3 (0.40) MEN1KMT2AEGLN1TDP1PKM
SCHEMBL8644278 0.75 MGAM (0.31) MEN1KMT2ATDP1PKMRAB9A
SCHEMBL14487029 0.75 GAA (0.58) TSHRMEN1KMT2AALDH1A1
SCHEMBL27153792 0.75 TSHR (0.50) PHF8KDM2ATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10364208-B2 Oxidative coupling of aryl boron reagents with SP3-carbon nucleophiles, and ambient decarboxylative arylation of malonate half-esters via oxidative catalysis THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2019-07-30 US claimed
US-20180186721-A1 OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2018-07-05 US claimed
CN-114874061-B Preparation method of prasugrel intermediate and analogues thereof 中国人民解放军海军军医大学 2023-12-22 CN disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-114874061-A Preparation method of prasugrel intermediate and analogue thereof 中国人民解放军海军军医大学 2022-08-09 CN disclosed
US-10364208-B2 Oxidative coupling of aryl boron reagents with SP3-carbon nucleophiles, and ambient decarboxylative arylation of malonate half-esters via oxidative catalysis THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2019-07-30 US disclosed
US-20180186721-A1 OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2018-07-05 US disclosed
US-20180186721-A1 OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2018-07-05 US disclosed
US-20050245563-A1 Chk-1 inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-11-03 US disclosed
WO-2005028474-A2 PYRAZOLOQUINOLINE DERIVATIVES AS CHK-1 INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245563-A1 Chk-1 inhibitors CHKA, CHKB, CHEK1 LDHA 3713/4885SRR 3436/4885PHF8 924/4885
US-10364208-B2 Oxidative coupling of aryl boron reagents with SP3-carbon nucleophiles, and ambient decarboxylative arylation of malonate half-esters via oxidative catalysis SOD1, AOC3, CBR3 LDHA 2014/4885SRR 540/4885PHF8 3692/4885
US-20180186721-A1 OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS SOD1, AOC3, CBR3 LDHA 2014/4885SRR 540/4885PHF8 3692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.